characterize genetic mutations that lead to immunotherapy resistance in melanoma The New York Genome Center-MRA Young Investigator Award, 2017-2020 Neville Sanjana, The New York Genome Center Down-regulating CTLA4 on effector T cells to improve anti-CTLA4 efficacy: Plans to test a therapeutic strategy to preve